The approval of ATZUMI and BREKIYA is expected to significantly reshape the migraine market by introducing new, innovative treatment options.

Xyrem (sodium oxybate) is a brand-name oral solution ... can increase the risk of side effects from Xyrem and COMT inhibitors divalproex (Depakote, Depakote ER) — can increase the risk of ...

Pierre Tariot, MD, Husseini Manji, MD, and Craig Nelson, MD, [1] discussed the identification of novel and unexpected targets of certain mood stabilizers, such as lithium and divalproex sodium.

Alembic Pharmaceuticals (Alembic) announced that it has received Final Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Divalproex Sodium Delayed ...

Alembic Pharmaceuticals announced that it has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Divalproex Sodium Delayed-Release ...

Depakote (DEH-pah-kote) is a brand name used in the United States for a type of medicine called divalproex (di-VAL-pro-eks) sodium. In the United States, Depakote ER is sold by Abbott Laboratories.

Divalproex sodium is a generic prescription drug that’s used to treat seizures and bipolar disorder. It’s also used to help prevent migraine. Divalproex sodium is not safe to take while ...

Sodium valproate, prescribed under brand names including Epilim, Belvo, Convulex and Depakote, is an effective treatment for epilepsy and bipolar disorder. The Medicines and Healthcare products ...

If the episodes are frequent, a preventative treatment can be considered with medications such as divalproex sodium (Depakote, Depakene), topiramate (Qudexy XR, Topamax, Trokendi XR), metoprolol ...